NBTK.DE vs. SBIO.L
Compare and contrast key facts about Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L).
NBTK.DE and SBIO.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. NBTK.DE is a passively managed fund by Invesco that tracks the performance of the Nasdaq Biotechnology. It was launched on Nov 6, 2014. SBIO.L is a passively managed fund by Invesco that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Nov 6, 2014. Both NBTK.DE and SBIO.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NBTK.DE or SBIO.L.
Correlation
The correlation between NBTK.DE and SBIO.L is 0.94, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
NBTK.DE vs. SBIO.L - Performance Comparison
Key characteristics
NBTK.DE:
0.32
SBIO.L:
0.23
NBTK.DE:
0.55
SBIO.L:
0.43
NBTK.DE:
1.07
SBIO.L:
1.05
NBTK.DE:
0.32
SBIO.L:
0.17
NBTK.DE:
1.10
SBIO.L:
0.67
NBTK.DE:
5.11%
SBIO.L:
6.22%
NBTK.DE:
17.67%
SBIO.L:
18.39%
NBTK.DE:
-30.99%
SBIO.L:
-39.44%
NBTK.DE:
-7.93%
SBIO.L:
-14.45%
Returns By Period
In the year-to-date period, NBTK.DE achieves a 2.58% return, which is significantly lower than SBIO.L's 6.83% return.
NBTK.DE
2.58%
0.70%
-2.53%
5.64%
4.03%
N/A
SBIO.L
6.83%
4.59%
-5.08%
5.67%
3.98%
2.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NBTK.DE vs. SBIO.L - Expense Ratio Comparison
Both NBTK.DE and SBIO.L have an expense ratio of 0.40%.
Risk-Adjusted Performance
NBTK.DE vs. SBIO.L — Risk-Adjusted Performance Rank
NBTK.DE
SBIO.L
NBTK.DE vs. SBIO.L - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NBTK.DE vs. SBIO.L - Dividend Comparison
Neither NBTK.DE nor SBIO.L has paid dividends to shareholders.
Drawdowns
NBTK.DE vs. SBIO.L - Drawdown Comparison
The maximum NBTK.DE drawdown since its inception was -30.99%, smaller than the maximum SBIO.L drawdown of -39.44%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and SBIO.L. For additional features, visit the drawdowns tool.
Volatility
NBTK.DE vs. SBIO.L - Volatility Comparison
The current volatility for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) is 4.14%, while Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a volatility of 5.21%. This indicates that NBTK.DE experiences smaller price fluctuations and is considered to be less risky than SBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.